# Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation

Study · id `cardio:ct-nct02695277` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02695277](<https://clinicaltrials.gov/study/NCT02695277>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02695277

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 146 participants.

## Technical summary

Registry record NCT02695277. Randomized; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2022-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 146 participants (enrolled count; ClinicalTrials.gov record NCT02695277, source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)
- Started: 2015-11 (actual) (ClinicalTrials.gov record NCT02695277, source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)
- Primary completion: 2022-11 (actual) (ClinicalTrials.gov record NCT02695277, source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)
- Completion: 2024-09 (actual) (ClinicalTrials.gov record NCT02695277, source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)
- Countries: Czechia; Germany; Netherlands; Poland; United Kingdom (ClinicalTrials.gov record NCT02695277, source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02695277-2024-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
- Acronym: CEASE-AF
- Condition: Atrial Fibrillation
- Condition: Persistent and Longstanding Persistent Atrial Fibrillation
- Intervention (Device): AtriCure Bipolar System
- Intervention (Device): Standard Endocardial Ablation with Catheter
- Intervention (Device): AtriClip® PRO LAA Exclusion System
- Intervention (Device): Endocardial Ablation with Catheter
- Intervention (Device): Repeated Endocardial ablation(s)
- Lead sponsor: AtriCure, Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Cardialysis BV
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: AtriCure, Inc. (`cardio:org-atricure-inc`)
- Registry lists this organization as a collaborator: Cardialysis BV (`cardio:org-cardialysis-bv`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Durable effectiveness and safety of hybrid ablation versus catheter ablation: 2-year results from the randomized CEASE-AF trial† (`cardio:pubmed-40711852`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 17f228b764f6f45bb0507bad28ef8b8e9e4cd5b489139c36343bfd67a09cef09
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
